Illumina

Illumina in Fortune Rankings

Updated:6/3/26
Country/Territory:U.S.
Headquarters:San Diego
Industry:Scientific,Photographic and Control Equipment
CEO:Jacob Thaysen
Website:https://www.illumina.com

Ticker:ILMN
Company type:Public
Revenues ($M):$4,343
Profits ($M):$850
Market value ($M):$18,847
Number of employees:9,340

Market value as of March 31, 2026.

Headquarters:San Diego, Calif.
Industry:Pharmaceuticals
Sector:Health Care
Current Streak:2
Years on List:4
CEO:Francis deSouza
Website:https://www.illumina.com

Revenue past four quarters ($M):$2,253
Net Income past four quarters ($M):$414

Revenue 3 Yr Growth Rank:61
EPS 3 Yr Annual Growth Rate:65%
EPS 3 Yr Growth Rank:25
Total Return 3 Yr Annual Rate:23%
Total Return 3 Yr Rank:54

Impact Segment:Public Health/Nutrition
Sector:Technology

Overall Score:1.4
Sector:Health Care

$ millions% change
Revenues ($M):$4,343-0.7%
Profits ($M):$850-
Assets ($M):$6,644-
Total Stockholder Equity ($M):$2,723-

Profit as % of Revenues:19.6%
Profits as % of Assets:12.8%
Profits as % of Stockholder Equity:31.2%

Earnings Per Share ($):5.50
EPS % Change (from prior fiscal year):-
EPS % Change (5 year annual rate):4.1%
EPS % Change (10 year annual rate):5.8%

Total Return to Investors (last year):-1.9%
Total Return to Investors (5 year, annualized):-18.3%
Total Return to Investors (10 year, annualized):-3.5%

Illumina stock chart

Latest news on Illumina

Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers

Illumina in Fortune Rankings

View the Full List

View the Full List

View the Full List

View the Full List

Videos